<DOC>
	<DOCNO>NCT00139685</DOCNO>
	<brief_summary>To evaluate compare Bone Mineral Density ( BMD ) adolescent Depo-Provera Contraceptive Injection ( DP150CI ) user depo medroxyprogesterone acetate ( DMPA ) therapy follow discontinuation DMPA . Another group elect non-hormonal contraception abstinence recruit reference population , across study site . The primary variable BMD , measure Dual Energy X-ray Absorptiometry ( DXA ) . Secondary variable : Total Body Composition &amp; Total Body Calcium ( TBC ) , measure Dual Energy X-ray Absorptiometry ( DXA ) , surrogate biologic BMD marker . Safety evaluate adverse event reporting , laboratory evaluation , pregnancy , weight vital sign .</brief_summary>
	<brief_title>Depo-Provera : Bone Mineral Density Total Body Calcium Adolescent DP150CI Users Non-Hormonal Contraception</brief_title>
	<detailed_description />
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Adolescent female menses 6 month prior enrollment Must negative pregnancy test Concomitant medication exclusion use bone modifying agent , glucocorticoid , heparin , anticonvulsant Screening Spinal BMD z score great 2 match young normal</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>